LXRX
Lexicon Pharmaceuticals Inc
NASDAQ: LXRX · HEALTHCARE · BIOTECHNOLOGY
$1.61
+3.87% today
Updated 2026-04-30
Market cap
$716.02M
P/E ratio
—
P/S ratio
14.38x
EPS (TTM)
$-0.14
Dividend yield
—
52W range
$1 – $2
Volume
2.4M
Lexicon Pharmaceuticals Inc (LXRX) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-56.91M | $-74.32M | $-95.60M | $-89.02M | $-82.37M | $-87.94M | $-94.46M | $-91.08M | $-75.62M | $184.78M | $-175.63M | $-185.39M | $-148.61M | $113.81M | $-142.97M | $-87.02M | $-88.85M | $-161.90M | $-178.78M | $-67.85M |
| Capital expenditures | $3.58M | $1.90M | $2.19M | $369000.00 | $1.13M | $1.21M | $492000.00 | $1.72M | $80000.00 | $910000.00 | $231000.00 | $228000.00 | $95000.00 | $70000.00 | $87000.00 | $1.22M | $1.33M | $470000.00 | $1.03M | $0.00 |
| Depreciation | $11.20M | $10.42M | $10.07M | $6.16M | $5.39M | $4.89M | $4.19M | $2.86M | $1.93M | $727000.00 | $2.06M | $3.40M | $3.68M | $3.65M | $2.93M | $292000.00 | $427000.00 | $554000.00 | $534000.00 | — |
| Stock-based comp | $7.03M | $7.93M | $6.50M | $5.27M | $5.48M | $5.71M | $6.50M | $7.42M | $7.08M | $6.84M | $7.45M | $9.47M | $11.70M | $14.22M | $13.27M | $10.58M | $11.52M | $14.34M | $13.50M | $12.52M |
| Free cash flow | $-60.49M | $-76.22M | $-97.79M | $-89.39M | $-83.50M | $-89.14M | $-94.95M | $-92.80M | $-75.70M | $183.87M | $-175.86M | $-185.62M | $-148.70M | $113.74M | $-143.06M | $-88.24M | $-90.18M | $-162.37M | $-179.81M | $-67.85M |
| Investing cash flow | $24.46M | $-187.95M | $159.41M | $11.88M | $-113.84M | $69.95M | $-97.81M | $99.54M | $-108.42M | $-117.02M | $18.25M | $50.52M | $169.58M | $-155.85M | $380.76M | $2.11M | $-71.08M | $-49.94M | $-15.38M | — |
| Financing cash flow | $40.70M | $254.99M | $-880000.00 | $91.82M | $142.87M | $157.08M | $36.38M | $-1.39M | $283.81M | $-2.03M | $987000.00 | $149.93M | $-2.24M | $-2.23M | $-147.64M | $22.71M | $142.21M | $187.96M | $238.35M | — |
| Dividends paid | — | — | — | — | — | $3.59M | $1.44M | $0.00 | $0.00 | $0.00 | $2.02M | $0.00 | — | — | $216.58M | $11.70M | — | $99.92M | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | $139.10M | $-155.89M | $7.08M | $99.77M | $65.72M | $-156.39M | $15.06M | $18.73M | $-44.27M | $90.15M | $-62.20M | $-17.72M | — | — | — |